{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:56:31Z","timestamp":1770666991874,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>We aimed to explore the temporal and spatial variations in mesothelioma incidence in Slovenia for the last 50 years and, among these, to evaluate the consequences of asbestos usage. The incidence data from the population-based Cancer Registry of Republic of Slovenia for the period 1961\u20132014 were analysed. The data of asbestos imported to Slovenia were used as a proxy for asbestos exposure in manufacturing areas. Log-linear joinpoint regression and age\u2013period\u2013cohort Poisson models were used in the time-trend analysis. The mesothelioma maps were produced according to the method of local standardized incidence ratio estimates and are presented together with the map of Slovenian major asbestos-exposed locations. The maximum value of the asbestos import curve corresponds to the peak of mesothelioma curve exactly 30 years later. Both increases before the peak are comparable in time interval and steepness. The highest mesothelioma risk was detected for the cohort born between 1940 and 1944. In maps, the mesothelioma clusters manifest around known asbestos sources predominantly in the years 1980\u20131990, but in the last few years, the geographical distribution is more dispersed. The data from our long-existing population-based cancer registry provide a good insight into the on-going mesothelioma epidemic in Slovenia. Our results imply that the mesothelioma peak has already been reached in Slovenia. In the future, new cases will emerge more randomly throughout the country.<\/jats:p>","DOI":"10.1097\/cej.0000000000000384","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T23:07:24Z","timestamp":1505344044000},"page":"S191-S196","source":"Crossref","is-referenced-by-count":9,"title":["Time trends and spatial patterns in the mesothelioma incidence in Slovenia, 1961\u20132014"],"prefix":"10.1097","volume":"26","author":[{"given":"Vesna","family":"Zadnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Primic Zakelj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Jarm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230905","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/089583799197203","article-title":"Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers","volume":"11","author":"Berry","year":"1999","journal-title":"Inhal Toxicol"},{"key":"R5-20230905","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/bjc.2013.514","article-title":"The latency period of mesothelioma among a cohort of British asbestos workers (1978\u20132005)","volume":"109","author":"Frost","year":"2013","journal-title":"Br J Cancer"},{"key":"R6-20230905","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/oemed-2015-103074","article-title":"Mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden","volume":"73","author":"Gilham","year":"2016","journal-title":"Occup Environ Med"},{"key":"R7-20230905","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0003-4878(00)00045-4","article-title":"The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure","volume":"44","author":"Hodgson","year":"2000","journal-title":"Ann Occup Hyg"},{"key":"R8-20230905","first-page":"1","article-title":"Non-asbestos related diffuse malignant mesothelioma","volume":"88","author":"Huncharek","year":"2002","journal-title":"Tumori"},{"key":"R10-20230905","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/1403494815596500","article-title":"Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden","volume":"43","author":"Jarvholm","year":"2015","journal-title":"Scand J Public Health"},{"key":"R11-20230905","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canep.2013.12.002","article-title":"Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994\u20132009","volume":"38","author":"Jennings","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"R13-20230905","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2471\/BLT.13.132118","article-title":"Asbestos: use, bans and disease burden in Europe","volume":"92","author":"Kameda","year":"2014","journal-title":"Bull World Health Organ"},{"key":"R14-20230905","first-page":"718","article-title":"Latent period for malignant mesothelioma","volume":"34","author":"Lanphear","year":"1992","journal-title":"J Occup Med"},{"key":"R15-20230905","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ijc.24711","article-title":"Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005","volume":"126","author":"Le Stang","year":"2010","journal-title":"Int J Cancer"},{"key":"R16-20230905","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/1471-2407-13-528","article-title":"Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020","volume":"13","author":"Lopez-Abente","year":"2013","journal-title":"BMC Cancer"},{"key":"R17-20230905","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1183\/09031936.96.09091932","article-title":"The epidemiology of mesothelioma in historical context","volume":"9","author":"McDonald","year":"1996","journal-title":"Eur Respir J"},{"key":"R18-20230905","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1023\/A:1026300619747","article-title":"Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends","volume":"14","author":"Montanaro","year":"2003","journal-title":"Cancer Causes Control"},{"key":"R19-20230905","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1289\/ehp.11272","article-title":"Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment","volume":"116","author":"Nishikawa","year":"2008","journal-title":"Environ Health Perspect"},{"key":"R20-20230905","first-page":"491","article-title":"Malignant pleural mesothelioma: an epidemiological perspective","volume":"1","author":"Robinson","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"R22-20230905","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1536867X1101000405","article-title":"Age\u2013period\u2013cohort modelling","volume":"10","author":"Rutherford","year":"2010","journal-title":"Stata J"},{"key":"R25-20230905","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12995-016-0127-4","article-title":"Malignant mesothelioma incidence by nation-wide cancer registry: a population-based study","volume":"11","author":"Tomasson","year":"2016","journal-title":"J Occup Med Toxicol"},{"key":"R26-20230905","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2478\/10004-1254-61-2010-1939","article-title":"Mesothelioma risk associated with asbestos production in Slovenia","volume":"61","author":"Vudrag","year":"2010","journal-title":"Arh Hig Rada Toksikol"},{"key":"R27-20230905","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"R28-20230905","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1080\/02664763.2011.570314","article-title":"Local standardized incidence ratio estimation and comparison with other mapping methods for small geographical areas using Slovenian breast cancer data","volume":"38","author":"Zagar","year":"2011","journal-title":"J Appl Stat"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201709001-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T23:34:37Z","timestamp":1693956877000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201709001-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000384","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}